Sex-Based Metabolomic Differences in Obese Mice Therapy

Sex-Based Metabolomic Differences in Checkpoint Inhibitor Response

This poster from our partners at TD2 (Translational Drug Development) highlights significant differences in tumor growth inhibition and treatment responses between obese and control diet-fed mice. Dive into the data, including flow cytometry, proteomics, and metabolomics analyses, to uncover the role of obesity in shaping the tumor microenvironment and metabolic dependencies.